Melissa M. Mangala
405 Liverpool Street
Darlinghurst, NSW 2010, Australia
Darlinghurst, NSW 2010, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Refate identifies chemical compounds to target trans-regulatory networks for cellular conversion.
Journal: bioRxiv : the preprint server for biology
Published: July 17, 2025
Reduced connexin-43 expression, slow conduction and repolarisation dispersion in a model of hypertrophic cardiomyopathy.
Journal: Disease models & mechanisms
Published: July 20, 2023
Action Potential Morphology Accurately Predicts Proarrhythmic Risk for Drugs With Potential to Prolong Cardiac Repolarization.
Journal: Circulation. Arrhythmia and electrophysiology
Published: June 19, 2023
Cytoskeletal disarray increases arrhythmogenic vulnerability during sympathetic stimulation in a model of hypertrophic cardiomyopathy.
Journal: Scientific reports
Published: April 12, 2023
Pathophysiological metabolic changes associated with disease modify the proarrhythmic risk profile of drugs with potential to prolong repolarisation.
Journal: British journal of pharmacology
Published: February 21, 2021
Co-expression of calcium and hERG potassium channels reduces the incidence of proarrhythmic events.
Journal: Cardiovascular research
Published: June 16, 2020
Pharmacological activation of IKr in models of long QT Type 2 risks overcorrection of repolarization.
Journal: Cardiovascular research
Published: July 03, 2019
Development of induced pluripotent stem cells from a patient with hypertrophic cardiomyopathy who carries the pathogenic myosin heavy chain 7 mutation p.Arg403Gln.
Journal: Stem cell research
Published: October 26, 2018
Real-time monitoring of peptide grafting onto chitosan films using capillary electrophoresis.
Journal: Analytical and bioanalytical chemistry
Published: October 16, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026